Skip to Content
Morningstar

AmericaFirst Monthly Risk-On Risk-Off U ABRUX

Morningstar Medalist Rating
Medalist Rating as of | See America First Investment Hub
  • NAV / 1-Day Return 12.53  /  −1.80 %
  • Total Assets 4.7 Mil
  • Adj. Expense Ratio
    3.370%
  • Expense Ratio 3.370%
  • Distribution Fee Level —
  • Share Class Type —
  • Category Tactical Allocation
  • Investment Style Large Growth
  • Credit Quality / Interest Rate Sensitivity —
  • Status Open
  • TTM Yield —
  • Turnover 326%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 12:04 AM GMT+0

Morningstar’s Analysis ABRUX

Will ABRUX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable ABRUX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the ABRUX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of ABRUX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Weakness in AmericaFirst Monthly Risk-On Risk-Off U's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ABRUX

More ABRUX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 51.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

8.00 403,687
Cash and Equivalents

TG Therapeutics Inc

6.28 317,052
Healthcare

Monte Rosa Therapeutics Inc

6.10 308,191
Healthcare

Gritstone Bio Inc

6.09 307,483
Healthcare

Nu Holdings Ltd Ordinary Shares Class A

6.04 304,823
Financial Services

Eli Lilly and Co

5.36 270,730
Healthcare

Novo Nordisk A/S ADR

5.09 256,800
Healthcare

Micron Technology Inc

4.55 229,532
Technology

NVIDIA Corp

4.47 225,890
Technology

DraftKings Inc Ordinary Shares - Class A

4.09 206,388
Consumer Cyclical